Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8785422 | Brachytherapy | 2017 | 5 Pages |
Abstract
The addition of 6Â months of ADT to LDR brachytherapy for H-IR prostate cancer does not improve 5Â year prostate specific antigen control, and we no longer routinely recommended it.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Tom Pickles, W. James Morris, Mira Keyes,